Belief BioMed
Minhang
About Belief BioMed
Belief BioMed integrates research and development, manufacturing, and clinical application of gene therapy products. The company focuses on innovative gene therapies and has developed novel engineered adeno-associated virus (AAV) vectors. These vectors offer advantages over conventional AAV vectors. Belief BioMed collaborates with other biotech firms to explore new gene therapy potentials.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $204.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2022)
- Website: beliefbiomed.com
- Phone: +1 925 602 6140
Industries & Categories
Biotechnology, Clinical Trials, Collaboration, Manufacturing, Market Research
Social Profiles
Canonical: https://fsome.com/organization/belief-biomed-72990 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.